Doximity Inc (DOCS) concluded trading on Thursday at a closing price of $58.45, with 5.86 million shares of worth about $342.62 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.57% during that period and on May 15, 2025 the price saw a loss of about -1.76%. Currently the company’s common shares owned by public are about 133.45M shares, out of which, 129.05M shares are available for trading.
Stock saw a price change of -1.52% in past 5 days and over the past one month there was a price change of 9.81%. Year-to-date (YTD), DOCS shares are showing a performance of 9.48% which increased to 154.24% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $23.27 but also hit the highest price of $85.21 during that period. The average intraday trading volume for Doximity Inc shares is 2.35 million. The stock is currently trading 2.04% above its 20-day simple moving average (SMA20), while that difference is up 0.38% for SMA50 and it goes to 13.62% higher than SMA200.
Doximity Inc (NYSE: DOCS) currently have 133.45M outstanding shares and institutions hold larger chunk of about 66.56% of that.
The stock has a current market capitalization of $10.97B and its 3Y-monthly beta is at 1.39. PE ratio of stock for trailing 12 months is 58.34, while it has posted earnings per share of $1.00 in the same period. Its PEG reads 6.04 and has Quick Ratio of 8.67 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for DOCS, volatility over the week remained 4.52% while standing at 3.66% over the month.
Stock’s fiscal year EPS is expected to rise by 0.22% while it is estimated to increase by 13.41% in next year. EPS is likely to shrink at an annualized rate of 9.66% for next 5-years, compared to annual growth of 193.38% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on February 07, 2025 offering an Overweight rating for the stock and assigned a target price range of between $31 and $78 to it. Coverage by Leerink Partners stated Doximity Inc (DOCS) stock as an Outperform in their note to investors on February 07, 2025, suggesting a price target of $90 for the stock. On December 20, 2024, Stephens Initiated their recommendations, while on December 04, 2024, Mizuho Initiated their ratings for the stock with a price target of $55. Stock get a Neutral rating from Goldman on November 15, 2024.
